Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...
In a paper published in aBIOTECH, the authors introduce NLRSeek, a reannotation-based pipeline for comprehensive mining of ...
This study is led by associate professor Gan Ai and associate professor Jinding Liu (College of Plant Protection, Academy for Advanced ...
IRVING, Texas, Jan. 5, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation ...
The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...
Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...
As people grow older, the same brain chemistry that once supported sharp thinking and stable mood can quietly start to work ...
Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.